Skip to content
PubMed This is a summary of 8 peer-reviewed journal articles Updated
Pediatric Endocrinology · Central Precocious Puberty

When Will Puberty and Menarche Return After GnRH Treatment?

At a Glance

After GnRH agonist treatment for central precocious puberty, puberty generally resumes within a few months after suppression wears off. The first period usually occurs 12 to 18 months after the final injection or implant removal, but timing varies.

When your daughter completes her treatment for central precocious puberty, the medication’s suppressive effect gradually wears off after her last scheduled dose’s duration (or after her implant is removed). For girls with ovaries and a uterus treated for this condition, the first period (menarche) typically begins 12 to 18 months after the final injection, though it can occasionally happen sooner or later [1].

The Return of Hormonal Activity

The medication works by pausing the brain’s signals to the ovaries. Once the suppression wears off, her natural development system—the hypothalamic-pituitary-gonadal (HPG) axis—gradually resumes its signaling. Evidence is generally reassuring that pubertal development and reproductive function resume normally after this treatment, though individual recovery timelines will vary [2].

Early signs of hormonal recovery often return within a few months of the medication wearing off. Her body will begin producing luteinizing hormone (LH), follicle-stimulating hormone (FSH), and estrogen again. Because this resumption is gradual, you may notice physical signs of puberty progressing—such as resumed breast development or an increased growth rate—well before her first period arrives. Her doctor can monitor this physical progress during follow-up visits and will not necessarily need to run routine hormone blood tests unless there is a specific concern.

The Timeline to the First Period

While the timeframe for menarche is a common concern, clinical data provides a useful, though approximate, picture of what to expect:

  • Typical Averages: In a large review of clinical studies, girls experienced their first period an average of about 15.8 months after stopping treatment [1]. Several other cohort studies report similar averages, typically falling between 12 and 17 months [3][4][5].
  • Variation is Expected: It is important to know that periods can start before the 12-month mark, and it is also common for them to take longer. One clinical trial analysis found a median time of 18.3 months [6].
  • Irregular First Cycles: Once menarche does occur, her first few menstrual cycles may be irregular in timing. This is a normal part of the HPG axis maturing and usually does not indicate a problem with her recovery.

Factors Associated With Timing

While no single factor can perfectly predict an exact date, research identifies elements that may influence her specific timeline:

  • Bone Age (Skeletal Maturation): Girls with a more advanced “bone age” (how mature her skeleton appears on an X-ray) or more advanced breast development at the end of treatment tend to have a shorter wait before their first period [3][6][7].
  • Less Consistent Factors: Things like chronological age, body mass index (BMI), and treatment duration are not highly consistent predictors across different studies, meaning they should not be used in isolation to guess her timeline [5][6][8].

Practical Preparation and Follow-Up

Because the 12 to 18-month window is an average rather than a guarantee, do not wait a full year to prepare. Since her period could return sooner, it is best to take practical steps immediately after stopping treatment:

  • Pack a Kit: Have her keep period products (pads, period underwear) and spare clothing in her school bag or locker.
  • Identify a Safe Adult: Discuss who she can approach at school, such as the school nurse or a trusted teacher, if her period starts away from home.
  • Continued Monitoring: Continue attending follow-up appointments with her pediatric endocrinologist. They will monitor her growth velocity, pubertal signs, and sometimes her bone age to ensure she is on track.
  • When to Call: Contact her care team if you see no physical signs of pubertal resumption after a few months, if she reaches the doctor’s expected outer time limit without a period, or if she experiences unusually heavy or painful bleeding once her periods begin.

Common questions in this guide

How long after stopping GnRH agonists does the first period usually start?
For girls treated for central precocious puberty, the first period most often begins about 12 to 18 months after the final injection. The medication's effect also wears off after an implant is removed, and periods can come sooner or later than average.
What are the first signs that puberty is starting again?
Hormonal activity often returns within a few months after medication suppression wears off. Breast development, breast tenderness, or a faster growth rate can appear before the first period.
What can affect how soon menarche happens after treatment?
A more advanced bone age, meaning greater skeletal maturity, or more advanced breast development at the end of treatment is associated with a shorter wait. Chronological age, body mass index, and treatment length have not been consistent predictors across studies.
Is it normal for the first periods to be irregular?
Yes. The first few cycles may be irregular in timing while the brain-to-ovary hormone system matures, and this usually does not mean recovery is abnormal.
When should I contact my daughter's doctor after treatment?
Contact her care team if there are no physical signs of puberty after a few months, if she reaches the time limit her doctor set without a period, or if bleeding is unusually heavy or painful. Keep follow-up visits with her pediatric endocrinologist so growth, pubertal signs, and sometimes bone age can be monitored.
How can I help my daughter prepare for her first period?
Keep pads or period underwear and spare clothing in her school bag or locker, and identify a trusted adult at school she can approach. Talking about the emotional side of these changes can also help her feel prepared and supported.

Get notified when new evidence is published on Genetic central precocious puberty in female.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Long-Term Efficacy and Safety of Leuprorelin Treatment in Children with Central Precocious Puberty: A Systematic Review and Meta-Analysis.

    Hou L, Ying Y, Ye F, et al.

    Children (Basel, Switzerland) 2025; (12(6)) doi:10.3390/children12060712.

    PMID: 40564670
  2. 2

    Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial.

    Silverman LA, Neely EK, Kletter GB, et al.

    The Journal of clinical endocrinology and metabolism 2015; (100(6)):2354-63 doi:10.1210/jc.2014-3031.

    PMID: 25803268
  3. 3

    Clinical findings influencing time to menarche post gonadotropin-releasing hormone agonist therapy in central precocious puberty.

    Wu V, Zhao V, Issa R, et al.

    Annals of pediatric endocrinology & metabolism 2021; (26(3)):185-191 doi:10.6065/apem.2040220.110.

    PMID: 34015904
  4. 4

    Long-term outcomes of gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty.

    Hwangbo J, Kang E, Nam HK, et al.

    Annals of pediatric endocrinology & metabolism 2025; (30(1)):31-37 doi:10.6065/apem.2448038.019.

    PMID: 40049673
  5. 5

    Menarche timing after GnRHa treatment in cases of central precocious puberty or early and fast puberty.

    Deligozoglu D, Buyukyilmaz G, Gokdemir I, et al.

    European journal of pediatrics 2026; (185(5)).

    PMID: 41975089
  6. 6

    Timing of onset of menses after GnRH agonist treatment for central precocious puberty.

    Klein KO, Vargas Trujillo M, Dragnic S, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2024; (37(5)):451-461 doi:10.1515/jpem-2023-0543.

    PMID: 38618862
  7. 7

    No pubertal growth spurt, rapid bone maturation, and menarche post GnRHa treatment in girls with precocious puberty.

    Briscoe A, Chen K, Klein KO

    Journal of pediatric endocrinology & metabolism : JPEM 2022; (35(11)):1401-1409 doi:10.1515/jpem-2022-0389.

    PMID: 36114751
  8. 8

    Long-Term Outcomes of Gonadotropin-Releasing Hormone Analogue Therapy in Central Precocious Puberty: A Comparative Analysis of Obese and Normal-Weight Girls.

    Sakornyutthadej N, Pruksasri J, Mahachoklertwattana P, et al.

    Clinical endocrinology 2026; (105(5)):549-555 doi:10.1111/cen.70195.

    PMID: 42530118

This page explains the expected return of puberty and menarche after GnRH agonist treatment for informational purposes only and does not constitute medical advice. Your daughter's pediatric endocrinologist can interpret her individual timeline and advise when to seek care.